Navigation Links
Vaccine For Meningococcal Disease Trialled In Western Australia

A vaccine which could protect children from meningococcal disease is being trialled by researchers in Perth. Until now immunization against the disease has not been// available.

The researchers, from the Vaccine Trials Group at the Telethon Institute for Child Health Research and Princess Margaret Hospital for Children, hope that the vaccine will be effective against the meningococcal B strain which is the most common. It is responsible for 80% of the affected cases in Western Australia.

Toddlers aged between 18 and 36 months and adolescent children between 10 and 12 years of age are required for the research project
MAL
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
Breaking Medicine Technology:Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Regence Members in Oregon Can Now Access Provider Cost Information 50204 1Regence Members in Oregon Can Now Access Provider Cost Information 50204 2Regence Members in Oregon Can Now Access Provider Cost Information 50204 3OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 1OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 2OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 3OncoGenex Pharmaceuticals Files Shelf Registration Statement 12807 4Eating Animal Fat May Lead to Pancreatic Cancer 50199 1Eating Animal Fat May Lead to Pancreatic Cancer 50199 2Eating Animal Fat May Lead to Pancreatic Cancer 50199 3